Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions

Cites (473)

Items 201–400 of 471

1. iDTI-ESBoost: Identification of Drug Target Interaction Using Evolutionary and Structural Features with Boosting
   Farshid Rayhan, Sajid Ahmed, Swakkhar Shatabda, Dewan Md. Farid, Zaynab Mousavian, Abdollah Dehzangi, M. Sohel Rahman · 2017 · Scientific Reports
2. In-silico Prediction of Synergistic Anti-Cancer Drug Combinations Using Multi-omics Data
   Celebi, Remzi, Bear Don’t Walk, Oliver, Movva, Rajiv, Alpsoy, Semih, Dumontier, Michel · 2019 · Scientific Reports
3. Discovery of Multitarget-Directed Ligands against Alzheimer’s Disease through Systematic Prediction of Chemical–Protein Interactions
   Jiansong Fang, Yongjie Li, Rui Liu, Xiaocong Pang, Chao Li, Ranyao Yang, Yangyang He, Wenwen Lian, Ailin Liu, Guanhua Du · 2014 · Journal of Chemical Information and Modeling
4. Predictive approaches for drug combination discovery in cancer
   Seyed Ali Madani Tonekaboni, Laleh Soltan Ghoraie, Venkata SK. Manem, Benjamin Haibe‐Kains · 2016 · Briefings in Bioinformatics
5. Opportunities and challenges using artificial intelligence in ADME/Tox
   Barun Bhhatarai, W. Patrick Walters, Cornelis E. C. A. Hop, Guido Lanza, Sean Ekins · 2019 · Nature Materials
6. Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate
   Downey, Darragh, Dutta, Arpan, McKie, Shane, Dawson, Gerard R., Dourish, Colin T., Craig, Kevin, Smith, Mark A., McCarthy, Dennis J., Harmer, Catherine J., Goodwin, Guy M. et al. · 2016 · European Neuropsychopharmacology
7. Prediction of potential drug targets based on simple sequence properties
   Qingliang Li, Luhua Lai · 2007 · BMC Bioinformatics
8. What makes a good drug target?
   Isabella Gashaw, Peter Ellinghaus, Anette Sommer, Khusru Asadullah · 2011 · Drug Discovery Today
9. Predicting Parkinson's Disease Genes Based on Node2vec and Autoencoder
   Jiajie Peng, Jiaojiao Guan, Xuequn Shang · 2019 · Frontiers in Genetics
10. MLMDA: a machine learning approach to predict and validate MicroRNA–disease associations by integrating of heterogenous information sources
    Kai Zheng, Zhu‐Hong You, Lei Wang, Yong Zheng Zhou, Liping Li, Zhengwei Li · 2019 · Journal of Translational Medicine
11. Population-based De Novo Molecule Generation, Using Grammatical Evolution
    Naruki Yoshikawa, Kei Terayama, Masato Sumita, Teruki Homma, Kenta Oono, Koji Tsuda · 2018 · Chemistry Letters
12. deepDriver: Predicting Cancer Driver Genes Based on Somatic Mutations Using Deep Convolutional Neural Networks
    Luo, Ping, Ding, Yulian, Lei, Xiujuan, Wu, Fang-Xiang · 2019 · Frontiers in Genetics
13. Recent progresses in the exploration of machine learning methods as in-silico ADME prediction tools
    Lin Tao, P. Zhang, C. Qin, Shengfan Chen, Cheng Zhang, Z. Chen, Feng Zhu, Shuyuan Yang, Y.Q. Wei, Yu Chen · 2015 · Advanced Drug Delivery Reviews
14. Drug-target interaction prediction using ensemble learning and dimensionality reduction
    Ali Ezzat, Min Wu, Xiaoli Li, Chee-Keong Kwoh · 2017 · Methods
15. Machine learning-assisted neurotoxicity prediction in human midbrain organoids
    Anna Sophia Monzel, Kathrin Hemmer, Tony Kaoma, Lisa M. Smits, Silvia Bolognin, Philippe Lucarelli, Isabel Rosety, Alise Žagare, Paul M. A. Antony, Sarah Nickels et al. · 2020 · Parkinsonism & Related Disorders
16. Redefining the Protein Kinase Conformational Space with Machine Learning
    Peter M.U. Ung, Rayees Rahman, Avner Schlessinger · 2018 · Cell chemical biology
17. Automated de novo molecular design by hybrid machine intelligence and rule-driven chemical synthesis
    Alexander L. Button, Daniel Merk, Jan A. Hiss, Gisbert Schneider · 2019 · Nature Machine Intelligence
18. Chemical Space Mimicry for Drug Discovery
    William Yuan, Dadi Jiang, Dhanya K. Nambiar, Lydia P. Liew, Michael P. Hay, Joshua Daniel Bloomstein, Peter Lu, Brandon E. Turner, Quynh‐Thu Le, Robert John Tibshirani et al. · 2017 · Journal of Chemical Information and Modeling
19. Data integration and predictive modeling methods for multi-omics datasets
    Minseung Kim, Ilias Tagkopoulos · 2017 · Molecular Omics
20. Development of a prediction model for hypotension after induction of anesthesia using machine learning
    Ah Reum Kang, Ji-Hyun Lee, Woohyun Jung, Misoon Lee, Sun Young Park, Jiyoung Woo, Sang Hyun Kim · 2020 · PLoS ONE
21. Quantitative structure–activity relationship prediction of blood-to-brain partitioning behavior using support vector machine
    Hassan Golmohammadi, Zahra Dashtbozorgi, William E. Acree · 2012 · European Journal of Pharmaceutical Sciences
22. Autonomous Systems in Anesthesia: Where Do We Stand in 2020? A Narrative Review
    Cédrick Zaouter, Alexandre Joosten, Joseph B. Rinehart, Michel M. R. F. Struys, Thomas M. Hemmerling · 2020 · Anesthesia & Analgesia
23. Bayesian Models Leveraging Bioactivity and Cytotoxicity Information for Drug Discovery
    Sean Ekins, Robert C. Reynolds, Hiyun Kim, Mi-Sun Koo, Marilyn Ekonomidis, Meliza T. Talaue, Steve D. Paget, Lisa K. Woolhiser, Anne J. M. Lenaerts, Barry A. Bunin et al. · 2013 · Chemistry & Biology
24. Patient-specific data fusion defines prognostic cancer subtypes
    Yuan, Yinyin, Savage, Richard S., Markowetz, Florian · 2011 · PLoS Computational Biology
25. DriverDBv2: a database for human cancer driver gene research
    I‐Fang Chung, Chen‐Yang Chen, Shih-Chieh Su, Chia‐Yang Li, Kou‐Juey Wu, Hsei–Wei Wang, Wei‐Chung Cheng · 2015 · Nucleic Acids Research
26. Towards improving compound selection in structure-based virtual screening
    Bohdan Waszkowycz · 2008 · Drug Discovery Today
27. Global Bayesian Models for the Prioritization of Antitubercular Agents
    Philip Prathipati, Ngai Ling Ma, Thomas H. Keller · 2008 · Journal of Chemical Information and Modeling
28. Predict drug permeability to blood–brain-barrier from clinical phenotypes: drug side effects and drug indications
    Zhen Gao, Yang Chen, Xiaoshu Cai, Rong Xu · 2016 · Bioinformatics
29. The Chemical Basis of Pharmacology
    Michael J. Keiser, John J. Irwin, Brian K. Shoichet · 2010 · Biochemistry
30. Support Vector Machines for the Estimation of Aqueous Solubility
    Peter Lind, Tatiana V. Maltseva · 2003 · Journal of Chemical Information and Computer Sciences
31. Improved Prediction of Blood–Brain Barrier Permeability Through Machine Learning with Combined Use of Molecular Property-Based Descriptors and Fingerprints
    Yaxia Yuan, Fang Zheng, Chang‐Guo Zhan · 2018 · The AAPS Journal
32. Use of Machine Learning for Predicting Escitalopram Treatment Outcome From Electroencephalography Recordings in Adult Patients With Depression
    Andrey V. Zhdanov, Sravya Atluri, Willy Wong, Yasaman Vaghei, Zafiris Jeff Daskalakis, Daniel M. Blumberger, Benicio Noronha Frey, Peter Giacobbe, Raymond Wing Moon Lam, Roumen V. Milev et al. · 2020 · JAMA Network Open
33. The Search for Cytotoxic Synergy Between Anticancer Agents: a Case of Dorothy and the Ruby Slippers?
    William R. Greco, Hélène M. Faessel, Laurence M. Levasseur · 1996 · JNCI Journal of the National Cancer Institute
34. Enabling the Discovery and Virtual Screening of Potent and Safe Antimicrobial Peptides. Simultaneous Prediction of Antibacterial Activity and Cytotoxicity
    Valeria V. Kleandrova, Juan Manuel Ruso, Alejandro Speck‐Planche, M. Natália D. S. Cordeiro · 2016 · ACS Combinatorial Science
35. Improved Classification of Blood-Brain-Barrier Drugs Using Deep Learning
    Miao, Rui, Xia, Liang-Yong, Chen, Hao-Heng, Huang, Hai-Hui, Liang, Yong · 2019 · Scientific Reports
36. Identifying disease genes using machine learning and gene functional similarities, assessed through Gene Ontology
    Muhammad Asif, Hugo Martiniano, Astrid Moura Vicente, Francisco M. Couto · 2018 · PLoS ONE
37. Puzzling over schizophrenia: Schizophrenia as a pathway disease
    Patrick F. Sullivan · 2012 · Nature Medicine
38. Structure-based machine-guided mapping of amyloid sequence space reveals uncharted sequence clusters with higher solubilities
    Nikolaos N. Louros, Gabriele Orlando, Matthias De Vleeschouwer, Frédéric Rousseau, Joost W. H. Schymkowitz · 2020 · Nature Communications
39. Drug Repositioning for Schizophrenia and Depression/Anxiety Disorders: A Machine Learning Approach Leveraging Expression Data
    Kai Zhao, Hon‐Cheong So · 2018 · IEEE Journal of Biomedical and Health Informatics
40. Alignment-Free Prediction of a Drug−Target Complex Network Based on Parameters of Drug Connectivity and Protein Sequence of Receptors
    Dolores Viña, Eugenio Uriarte, Francisco Orallo, Humberto González‐Díaz · 2009 · Molecular Pharmaceutics
41. From the Cover: Developmental Neurotoxicants Disrupt Activity in Cortical Networks on Microelectrode Arrays: Results of Screening 86 Compounds During Neural Network Formation
    Christopher L. Frank, Jasmine P. Brown, Kathleen Wallace, William R. Mundy, Timothy J. Shafer · 2017 · Toxicological Sciences
42. What makes a kinase promiscuous for inhibitors?
    Sonya M. Hanson, G. Georghiou, M. Thakur, W. Miller, J. Rest, J. Chodera, M. Seeliger · 2019 · Cell Chemical Biology
43. A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer's disease therapy: Analysis of the blarcamesine (ANAVEX2‐73) Phase 2a clinical study
    Hampel, Harald, Williams, Coralie, Etcheto, Adrien, Goodsaid, Federico, Parmentier, Frédéric, Sallantin, Jean, Kaufmann, Walter E., Missling, Christopher U., Afshar, Mohammad · 2020 · Alzheimer's & Dementia: Translational Research & Clinical Interventions
44. Electrotopological State Atom (E-State) Index in Drug Design, QSAR, Property Prediction and Toxicity Assessment
    Kunal Roy, Indrani Mitra · 2012 · Current Computer - Aided Drug Design
45. A machine learning approach for genome-wide prediction of morbid and druggable human genes based on systems-level data
    Pedro Rafael Costa, Márcio Luís Acencio, Ney Lemke · 2010 · BMC Genomics
46. Prediction of Potential Disease-Associated MicroRNAs by Using Neural Networks
    Xiangxiang Zeng, Wen Wang, Gaoshan Deng, Jiaxin Bing, Quan Zou · 2019 · Molecular Therapy — Nucleic Acids
47. Prediction of drug adverse events using deep learning in pharmaceutical discovery
    Chun Yen Lee, Yi‐Ping Phoebe Chen · 2020 · Briefings in Bioinformatics
48. Profile-QSAR 2.0: Kinase Virtual Screening Accuracy Comparable to Four-Concentration IC50s for Realistically Novel Compounds
    Éric Martin, Valery R. Polyakov, Li Tian, Rolando Perez · 2017 · Journal of Chemical Information and Modeling
49. Antidepressant Response in Patients With Major Depression Exposed to NSAIDs: A Pharmacovigilance Study
    Patience Gallagher, Victor Manuel Castro, Maurizio Fava M. D, Jeffrey B. Weilburg, Shawn N. Murphy, Vivian S. Gainer, Susanne E. Churchill, Isaac S. Kohane, Dan Vlad Iosifescu, Jordan W. Smoller et al. · 2012 · American Journal of Psychiatry
50. Constructing and Validating High-Performance MIEC-SVM Models in Virtual Screening for Kinases: A Better Way for Actives Discovery
    Huiyong Sun, Peichen Pan, Sheng Tian, Lei Xu, Xiaotian Kong, Youyong Li, Dan Li, Tingjun Hou · 2016 · Scientific Reports
51. Utilizing random Forest QSAR models with optimized parameters for target identification and its application to target-fishing server
    Kyoungyeul Lee, Minho Lee, Dongsup Kim · 2017 · BMC Bioinformatics
52. Novel Consensus Architecture To Improve Performance of Large-Scale Multitask Deep Learning QSAR Models
    Alexey V. Zakharov, Tongan Zhao, Ðắc-Trung Nguyễn, Tyler Peryea, Timothy K. Sheils, Adam Yasgar, Ruili Huang, Noel T Southall, Anton M. Simeonov · 2019 · Journal of Chemical Information and Modeling
53. Integrative deep models for alternative splicing
    Anupama Jha, Matthew R. Gazzara, Yoseph Barash · 2017 · Bioinformatics
54. Protein structure prediction beyond AlphaFold
    Guo‐Wei Wei · 2019 · Nature Machine Intelligence
55. Drug-target interaction prediction with tree-ensemble learning and output space reconstruction
    Konstantinos Pliakos, Celine Vens · 2020 · BMC Bioinformatics
56. Neural Networks: Accurate Nonlinear QSAR Model for HEPT Derivatives
    Latifa Douali, Didier Villemin, Driss Cherqaoui · 2003 · Journal of Chemical Information and Computer Sciences
57. QSAR Modeling and Prediction of Drug–Drug Interactions
    Alexey V. Zakharov, Ekaterina V. Varlamova, Alexey A. Lagunin, Alexander V. Dmitriev, Eugene N. Muratov, Denis Fourches, V. Е. Kuz’min, Vladimir Poroikov, Alexander Tropsha, Marc C. Nicklaus · 2015 · Molecular Pharmaceutics
58. The Human Genome Project, and recent advances in personalized genomics
    Brenda J. Wilson, Stuart Gordon Nicholls · 2015 · Risk Management and Healthcare Policy
59. Similarity-based prediction for Anatomical Therapeutic Chemical classification of drugs by integrating multiple data sources
    Zhongyang Liu, Feifei Guo, Jiangyong Gu, Yong Wang, Yang Li, Dan Wang, Liang Lu, Dong Li, Fuchu He · 2015 · Bioinformatics
60. Evolutionarily conserved roles for blood-brain barrier xenobiotic transporters in endogenous steroid partitioning and behavior
    Hindle, Samantha J., Munji, Roeben N., Dolghih, Elena, Gaskins, Garrett, Orng, Souvinh, Ishimoto, Hiroshi, Soung, Allison, DeSalvo, Michael, Kitamoto, Toshihiro, Keiser, Michael J. et al. · 2017 · Cell Reports
61. Toxoplasma gondii and the blood-brain barrier
    Sabrina M. Feustel, Markus Meissner, Oliver Liesenfeld · 2012 · Virulence
62. Systematic identification of feature combinations for predicting drug response with Bayesian multi-view multi-task linear regression
    Muhammad Ammad-ud-din, Suleiman A. Khan, Krister Wennerberg, Tero A. Aittokallio · 2017 · Bioinformatics
63. Improving individual predictions: Machine learning approaches for detecting and attacking heterogeneity in schizophrenia (and other psychiatric diseases)
    Hugo Gerard Schnack · 2017 · Schizophrenia Research
64. Kernel-based data fusion improves the drug–protein interaction prediction
    Yongcui Wang, Chunhua Zhang, Nai-Yang Deng, Yong Wang · 2011 · Computational Biology and Chemistry
65. Drug-Target Interaction Prediction: End-to-End Deep Learning Approach
    Nelson R. C. Monteiro, Bernardete Ribeiro, Joel Perdiz Arrais · 2020 · IEEE Transactions on Computational Biology and Bioinformatics
66. Artificial Neural Networks and Linear Discriminant Analysis: A Valuable Combination in the Selection of New Antibacterial Compounds
    Miguel Murcia‐Soler, Facundo Pérez‐Giménez, Francisco J. Garcı́a-March, Ma Teresa Salabert-Salvador, Wladimiro Dı́az-Villanueva, María José Castro-Bleda, Angel Villanueva‐Pareja · 2004 · Journal of Chemical Information and Computer Sciences
67. Protein–Ligand Empirical Interaction Components for Virtual Screening
    Yuna Yan, Weijun Wang, Zhaoxi Sun, John Z. H. Zhang, Changge Ji · 2017 · Journal of Chemical Information and Modeling
68. Can human experts predict solubility better than computers?
    Samuel Boobier, Anne Osbourn, John B. O. Mitchell · 2017 · Journal of Cheminformatics
69. Mind and machine in drug design
    Gisbert Schneider · 2019 · Nature Machine Intelligence
70. Speeding up Early Drug Discovery in Antiviral Research: A Fragment-Based in Silico Approach for the Design of Virtual Anti-Hepatitis C Leads
    Alejandro Speck‐Planche, M. Natália D. S. Cordeiro · 2017 · ACS Combinatorial Science
71. Primary functional brain connections associated with melancholic major depressive disorder and modulation by antidepressants
    Naho Ichikawa, Giuseppe Lisi, Noriaki Yahata, Go Okada, Masahiro Takamura, Ryu-ichiro Hashimoto, Takashi Yamada, Makiko Yamada, Tetsuya Suhara, Sho Moriguchi et al. · 2020 · Scientific Reports
72. Novel Bayesian classification models for predicting compounds blocking hERG potassium channels
    Lili Liu, Jing Lu, Yin Lu, Ming-yue Zheng, Xiaomin Luo, Weiliang Zhu, Hualiang Jiang, Kaixian Chen · 2014 · Acta Pharmacologica Sinica
73. logD7.4 Modeling Using Bayesian Regularized Neural Networks. Assessment and Correction of the Errors of Prediction
    Pierre Bruneau, Nathan R. McElroy · 2005 · Journal of Chemical Information and Modeling
74. Revealing the Macromolecular Targets of Fragment‐Like Natural Products
    Tiago Rodrigues, Daniel Reker, Jens Kunze, Petra Schneider, Gisbert Schneider · 2015 · Angewandte Chemie International Edition
75. Binding Affinity Prediction for Protein–Ligand Complexes Based on β Contacts and B Factor
    Qian Liu, Chee Keong Kwoh, Jinyan Li · 2013 · Journal of Chemical Information and Modeling
76. Prediction of Druggable Proteins Using Machine Learning and Systems Biology: A Mini-Review
    Gaurav Kandoi, Márcio Luís Acencio, Ney Lemke · 2015 · Frontiers in Physiology
77. Network pharmacology-based analysis of Chinese herbal Naodesheng formula for application to Alzheimer's disease
    Xiao-Cong PANG, De Kang, Jiansong Fang, Ying Zhao, Lvjie Xu, Wenwen Lian, Ailin Liu, Guanhua Du · 2018 · Chinese Journal of Natural Medicines
78. Adversarial Controls for Scientific Machine Learning
    Kangway V. Chuang, Michael J. Keiser · 2018 · ACS Chemical Biology
79. Bayesian varying coefficient kernel machine regression to assess neurodevelopmental trajectories associated with exposure to complex mixtures
    Shelley H. Liu, Jennifer F. Bobb, Birgit Claus Henn, Chris Gennings, Lourdes Schnaas, Martha María Téllez‐Rojo, David C. Bellinger, Manish Arora, Robert O. Wright, Brent A. Coull · 2018 · Statistics in Medicine
80. Machine learning prediction of oncology drug targets based on protein and network properties
    Zoltán Dezső, Michele Ceccarelli · 2020 · BMC Bioinformatics
81. Target-Specific Support Vector Machine Scoring in Structure-Based Virtual Screening: Computational Validation, In Vitro Testing in Kinases, and Effects on Lung Cancer Cell Proliferation
    Liwei Li, May Khanna, Inha Jo, Fang Wang, Nicole M. Ashpole, Andy Hudmon, Samy O. Meroueh · 2011 · Journal of Chemical Information and Modeling
82. BgN-Score and BsN-Score: Bagging and boosting based ensemble neural networks scoring functions for accurate binding affinity prediction of protein-ligand complexes
    Hossam M. Ashtawy, Nihar R. Mahapatra · 2015 · BMC Bioinformatics
83. Capsule Networks Showed Excellent Performance in the Classification of hERG Blockers/Nonblockers
    Yiwei Wang, Lei Huang, Siwen Jiang, Yifei Wang, Jun Zou, Hongguang Fu, Shengyong Yang · 2020 · Frontiers in Pharmacology
84. Fragment-based in silico modeling of multi-target inhibitors against breast cancer-related proteins
    Alejandro Speck‐Planche, M. Natália D. S. Cordeiro · 2017 · Molecular Diversity
85. Prediction of aqueous solubility of druglike organic compounds using partial least squares, back‐propagation network and support vector machine
    Dongsheng Cao, Qing‐Song Xu, Yi‐Zeng Liang, Chen Xian, Hong‐Dong Li · 2010 · Journal of Chemometrics
86. Ensemble Prediction of Synergistic Drug Combinations Incorporating Biological, Chemical, Pharmacological, and Network Knowledge
    Pingjian Ding, Rui Yin, Jiawei Luo, Chee Keong Kwoh · 2018 · IEEE Journal of Biomedical and Health Informatics
87. The role of fMRI in drug development
    Owen Thomas Carmichael, Adam James Schwarz, Christopher Hughes Chatham, David Scott, Jessica A. Turner, Jaymin Upadhyay, Alexandre Coimbra, James A Goodman, Richard Baumgartner, Brett A. English et al. · 2017 · Drug Discovery Today
88. Neuroanatomical heterogeneity of schizophrenia revealed by semi-supervised machine learning methods
    Nicolas Honnorat, Aoyan Dong, Eva Meisenzahl‐Lechner, Nikolaos Koutsouleris, Christos A. Davatzikos · 2017 · Schizophrenia Research
89. Predicting inadequate postoperative pain management in depressed patients: A machine learning approach
    Arjun Parthipan, Imon Banerjee, Keith N. Humphreys, Steven M. Asch, Catherine Mills Curtin, Ian Richard Carroll, Tina Hernandez‐Boussard · 2019 · PLoS ONE
90. Use of Mobile Health Apps and Wearable Technology to Assess Changes and Predict Pain During Treatment of Acute Pain in Sickle Cell Disease: Feasibility Study
    Amanda K. Johnson, Fan Yang, Sid Gollarahalli, Tanvi Banerjee, Daniel M. Abrams, Jude Jonassaint, Charles Richard Jonassaint, Nirmish Shah · 2019 · JMIR mhealth and uhealth
91. Biosignatures for Parkinson’s Disease and Atypical Parkinsonian Disorders Patients
    Judith A. Potashkin, José A. Santiago, Bernard M. Ravina, Arthur Watts, Alexey A. Leontovich · 2012 · PLoS ONE
92. An extensive analysis of disease-gene associations using network integration and fast kernel-based gene prioritization methods
    Giorgio Valentini, Alberto Paccanaro, Horacio Caniza, Alfonso E. Romero, Matteo Ré · 2014 · Artificial Intelligence in Medicine
93. The role of multidrug resistance protein (MRP-1) as an active efflux transporter on blood–brain barrier (BBB) permeability
    Karthik Lingineni, Vilas Belekar, Sujit R. Tangadpalliwar, Prabha Garg · 2017 · Molecular Diversity
94. Recent developments in deep learning applied to protein structure prediction
    Shaun M. Kandathil, Joe G. Greener, David T. Jones · 2019 · Proteins Structure Function and Bioinformatics
95. Practical Applications of Deep Learning To Impute Heterogeneous Drug Discovery Data
    Benedict Irwin, Julian R. Levell, Thomas M. Whitehead, Matthew Segall, G. J. Conduit · 2020 · Journal of Chemical Information and Modeling
96. Prediction of drug–target interaction by label propagation with mutual interaction information derived from heterogeneous network
    Xiaoying Winston Yan, Shao‐Wu Zhang, Song-Yao Zhang · 2015 · Molecular BioSystems
97. Drug Analogs from Fragment-Based Long Short-Term Memory Generative Neural Networks
    Mahendra Awale, Finton Sirockin, Nikolaus Stiefl, Jean‐Louis Reymond · 2019 · Journal of Chemical Information and Modeling
98. Deep Reinforcement Learning for Optimal Critical Care Pain Management with Morphine using Dueling Double-Deep Q Networks
    Daniel Lopez-Martinez, Patrick C. Eschenfeldt, Sassan Ostvar, Myles A. Ingram, Chin Hur, Rosalind W. Picard · 2019 · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
99. Applications of Deep-Learning in Exploiting Large-Scale and Heterogeneous Compound Data in Industrial Pharmaceutical Research
    Laurianne David, Josep Arús‐Pous, Johan Karlsson, Ola Engkvist, Esben Jannik Bjerrum, Thierry Kogej, Jan M. Kriegl, Bernd Beck, Hongming Chen · 2019 · Frontiers in Pharmacology
100. BE-DTI’: Ensemble framework for drug target interaction prediction using dimensionality reduction and active learning
     Aman Sharma, Rinkle Rani · 2018 · Computer Methods and Programs in Biomedicine
101. Machine Learning-Assisted Network Inference Approach to Identify a New Class of Genes that Coordinate the Functionality of Cancer Networks
     Mehrab Ghanat Bari, Choong Yong Ung, Cheng Zhang, Shizhen Zhu, Hu Li · 2017 · Scientific Reports
102. Machine Learning From Molecular Dynamics Trajectories to Predict Caspase-8 Inhibitors Against Alzheimer’s Disease
     Salma Jamal, Abhinav Grover, Sonam Grover · 2019 · Frontiers in Pharmacology
103. LOTUS: A single- and multitask machine learning algorithm for the prediction of cancer driver genes
     Olivier Collier, Véronique Stoven, Jean‐Philippe Vert · 2019 · PLoS Computational Biology
104. Machine learning approach to predict medication overuse in migraine patients
     Patrizia Ferroni, Fabio Massimo Zanzotto, Noemi Scarpato, Antonella Spila, Luisa Fofi, Gabriella Egeo, Alessandro Rullo, Raffaele Palmirotta, Piero Barbanti, Fiorella Guadagni · 2020 · Computational and Structural Biotechnology Journal
105. Pharmaco-fUS: Quantification of pharmacologically-induced dynamic changes in brain perfusion and connectivity by functional ultrasound imaging in awake mice
     Claire Rabut, Jérémy Ferrier, Adrien Bertolo, Bruno-Félix Osmanski, Xavier Mousset, Sophie Pezet, Thomas Deffieux, Zsolt Lenkei, Mickaël Tanter · 2020 · NeuroImage
106. Selective serotonin 5-HT1A receptor biased agonists elicitdistinct brain activation patterns: a pharmacoMRI study
     Guillaume Becker, Radu I. Bolbos, Nicolas Costes, Jérôme Redouté, Adrian Newman‐Tancredi, Luc Zimmer · 2016 · Scientific Reports
107. Dexmedetomidine-induced deep sedation mimics non-rapid eye movement stage 3 sleep: large-scale validation using machine learning
     Sowmya Muchukunte Ramaswamy, Maud A. S. Weerink, Michel M. R. F. Struys, Sunil Belur Nagaraj · 2020 · SLEEP
108. Recent approaches to the prioritization of candidate disease genes
     Nadezhda T. Doncheva, Tim Kacprowski, Mario Albrecht · 2012 · WIREs Systems Biology and Medicine
109. Binary Classification of Aqueous Solubility Using Support Vector Machines with Reduction and Recombination Feature Selection
     Tiejun Cheng, Qingliang Li, Yanli Wang, Stephen H. Bryant · 2011 · Journal of Chemical Information and Modeling
110. Simultaneous Virtual Prediction of Anti- Escherichia coli Activities and ADMET Profiles: A Chemoinformatic Complementary Approach for High-Throughput Screening
     Alejandro Speck‐Planche, M. Natália D. S. Cordeiro · 2014 · ACS Combinatorial Science
111. Predicted Biological Activity of Purchasable Chemical Space
     John J. Irwin, Garrett Gaskins, Teague Sterling, Michael M. Mysinger, Michael J. Keiser · 2017 · Journal of Chemical Information and Modeling
112. DeepProfile: Deep learning of cancer molecular profiles for precision medicine
     Ayse Berceste Dincer, Safiye Celik, Naozumi Hiranuma, Su‐In Lee · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
113. ANN multiplexing model of drugs effect on macrophages; theoretical and flow cytometry study on the cytotoxicity of the anti-microbial drug G1 in spleen
     Esvieta Tenorio-Borroto, Claudia Giovanna Peñuelas-Rívas, Juan C. Vásquez Chagoyán, Nilo Castañedo, Francisco Prado-Prado, Xerardo Garcia-mera B, Humberto González‐Díaz · 2012 · Bioorganic & Medicinal Chemistry
114. New insights toward the discovery of antibacterial agents: Multi-tasking QSBER model for the simultaneous prediction of anti-tuberculosis activity and toxicological profiles of drugs
     Alejandro Speck‐Planche, Valeria V. Kleandrova, M. Natália D. S. Cordeiro · 2013 · European Journal of Pharmaceutical Sciences
115. Schizophrenia: A neurodevelopmental disorder — Integrative genomic hypothesis and therapeutic implications from a transgenic mouse model
     Michal K. Stachowiak, Aaron J. Kucinski, Richard Curl, C. Syposs, Yu Yang, Sridhar Tatarao Narla, Christopher J. Terranova, Dorota Prokop, Ilona Klejbor, Merouane Bencherif et al. · 2012 · Schizophrenia Research
116. A Network-Based Classification Model for Deriving Novel Drug-Disease Associations and Assessing Their Molecular Actions
     Min Oh, Jaegyoon Ahn, Youngmi Yoon · 2014 · PLoS ONE
117. Serum N-Glycosylation in Parkinson’s Disease: A Novel Approach for Potential Alterations
     Csaba Váradi, Károly Nehéz, Olivér Hornyák, Béla Viskolcz, Jonathan Bones · 2019 · Molecules
118. Identifying schizophrenia subgroups using clustering and supervised learning
     Talpalaru, Alexandra, Bhagwat, Nikhil, Devenyi, Gabriel A., Lepage, Martin, Chakravarty, M. Mallar · 2019 · Schizophrenia Research
119. Predicting Drug-Disease Associations via Using Gaussian Interaction Profile and Kernel-Based Autoencoder
     Han-Jing Jiang, Yu‐An Huang, Zhu-Hong You · 2019 · BioMed Research International
120. Machine learning discriminates a movement disorder in a zebrafish model of Parkinson's disease
     Gideon L. Hughes, Michael A. Lones, Matthew Bedder, Peter David Currie, Stephen L. Smith, Mary Elizabeth Pownall · 2020 · Disease Models & Mechanisms
121. A recursive-partitioning model for blood–brain barrier permeation
     Scot Mente, Franco Lombardo · 2005 · Journal of Computer-Aided Molecular Design
122. CSCORE: A SIMPLE YET EFFECTIVE SCORING FUNCTION FOR PROTEIN–LIGAND BINDING AFFINITY PREDICTION USING MODIFIED CMAC LEARNING ARCHITECTURE
     Xuchang Ouyang, Stephanus Daniel Handoko, Chee Keong Kwoh · 2011 · Journal of Bioinformatics and Computational Biology
123. Protein function in precision medicine: deep understanding with machine learning
     Burkhard Rost, Predrag Radivojac A, Yana Bromberg · 2016 · FEBS Letters
124. Improving the Virtual Screening Ability of Target-Specific Scoring Functions Using Deep Learning Methods
     Dingyan Wang, Chen Cui, Xiaoyu Ding, Zhaoping Xiong, Mingyue Zheng, Xiaomin Luo, Hualiang Jiang, Kaixian Chen · 2019 · Frontiers in Pharmacology
125. Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure
     Daniel J. Mason, Ian P. Stott, Stephanie Kay Ashenden, Zohar Weinstein, Idil Karakoc, Selin Meral, Nurdan Kuru, Andreas Bender, Murat Cokol · 2017 · Journal of Medicinal Chemistry
126. Effective connectivity within a triple network brain system discriminates schizophrenia spectrum disorders from psychotic bipolar disorder at the single-subject level
     Lena K. Palaniyappan, Gopikrishna Deshpande, Pradyumna Lanka, D. Rangaprakash, Sarina Jennifer Iwabuchi, Susan Francis, Peter Francis Liddle · 2018 · Schizophrenia Research
127. HENA, heterogeneous network-based data set for Alzheimer’s disease
     Elena Sügis, Jérôme Dauvillier, Anna Leontjeva, Priit Adler, Valérie Hindie, Thomas Moncion, Vincent Collura, Rachel Daudin, Yann Loe-Mie, Yann Hérault et al. · 2019 · Scientific Data
128. Correction to “admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties”
     Feixiong Cheng, Weihua Li, Yadi Zhou, Jie Shen, Zengrui Wu, Guixia Liu, Philip W. Lee, Yun Tang · 2019 · Journal of Chemical Information and Modeling
129. Prediction and validation of enzyme and transporter off-targets for metformin
     Sook Wah Yee, Lawrence Lin, Matthew Merski, Michael J. Keiser, Aakash Gupta, Youcai Zhang, Huan‐Chieh Chien, Brian K. Shoichet, Kathleen M. Giacomini · 2015 · Journal of Pharmacokinetics and Pharmacodynamics
130. Can the Latest Computerized Technologies Revolutionize Conventional Assessment Tools and Therapies for a Neurological Disease? The Example of Parkinson’s Disease
     Tetsuya Asakawa, Kenji Sugiyama, Takao Nozaki, Tetsuro Sameshima, Susumu KOBAYASHI, Liang You Wang, Zhen Hong, Shujiao Chen, Candong Li, Hiroki Namba · 2019 · Neurologia medico-chirurgica
131. In Silico Prediction of PAMPA Effective Permeability Using a Two-QSAR Approach
     Cheng-Ting Chi, Ming-Han Lee, Ching‐Feng Weng, Max K. Leong · 2019 · International Journal of Molecular Sciences
132. Predicting escitalopram monotherapy response in depression: The role of anterior cingulate cortex
     Shui Tian, Yurong Sun, Junneng Shao, Siqi Zhang, Zhaoqi Mo, Xiaoxue Liu, Qiang Wang, Li Wang, Peng Zhao, Mohammad Ridwan Chattun et al. · 2019 · Human Brain Mapping
133. Assessment of response to medication in individuals with Parkinson’s disease
     Murtadha D. Hssayeni, Michelle A. Burack, Joohi Jimenez Shahed, Behnaz Ghoraani · 2019 · Medical Engineering & Physics
134. Prediction of drug-disease associations based on ensemble meta paths and singular value decomposition
     Guangsheng Wu, Juan Liu, Xiang Yue · 2019 · BMC Bioinformatics
135. DrugR+: A comprehensive relational database for drug repurposing, combination therapy, and replacement therapy
     Yosef Masoudi‐Sobhanzadeh, Yadollah Omidi, Massoud Amanlou, Ali Masoudi‐Nejad · 2019 · Computers in Biology and Medicine
136. Repurposing Approved Drugs as Inhibitors of Kv7.1 and Nav1.8 to Treat Pitt Hopkins Syndrome
     Sean Ekins, Jacob Gerlach, Kimberley M. Zorn, Brett M. Antonio, Zhixin Lin, Aaron C. Gerlach · 2019 · Pharmaceutical Research
137. From Patient-Controlled Analgesia to Artificial Intelligence-Assisted Patient-Controlled Analgesia: Practices and Perspectives
     Rui Wang, Shaoshuang Wang, Na Duan, Qiang Wang · 2020 · Frontiers in Medicine
138. Simultaneous Modeling of Antimycobacterial Activities and ADMET Profiles: A Chemoinformatic Approach to Medicinal Chemistry
     Alejandro Speck‐Planche, M. Natália D. S. Cordeiro · 2013 · Current Topics in Medicinal Chemistry
139. Discovery of indolylpiperazinylpyrimidines with dual-target profiles at adenosine A2A and dopamine D2 receptors for Parkinson's disease treatment
     Yi Ming Shao, Xiaohua Ma, Priyankar Paira, Aaron Tan, Deron Raymond Herr, Kah Leong Lim, Chee H. Ng, Gopalakrishnan Venkatesan, Karl‐Norbert Klotz, Stephanie Federico et al. · 2018 · PLoS ONE
140. Model for high-throughput screening of drug immunotoxicity – Study of the anti-microbial G1 over peritoneal macrophages using flow cytometry
     Esvieta Tenorio-Borroto, Claudia Giovanna Peñuelas-Rívas, Juan Carlos Vázquez-Chagoyán, Nilo Castañedo, Francisco Prado-Prado, Xerardo Garcia-mera B, Humberto González‐Díaz · 2013 · European Journal of Medicinal Chemistry
141. Chemoinformatics in Multi-target Drug Discovery for Anti-cancer Therapy: In Silico Design of Potent and Versatile Anti-brain Tumor Agents
     Alejandro Speck‐Planche, Valeria V. Kleandrova, Feng Luan, M. Natália D. S. Cordeiro · 2012 · Anti-Cancer Agents in Medicinal Chemistry
142. AVISPA: a web tool for the prediction and analysis of alternative splicing
     Yoseph Barash, Jorge Vaquero-Garcia, Juan González‐Vallinas, Hui Yuan Xiong, Weijun Gao, Leo J. Lee, Brendan J. Frey · 2013 · Genome biology
143. QSAR Classification Model for Antibacterial Compounds and Its Use in Virtual Screening
     Narender Pal Singh, Sidhartha Chaudhury, Ruifeng Liu, Mohamed Diwan M. AbdulHameed, Gregory J. Tawa, Anders Wallqvist · 2012 · Journal of Chemical Information and Modeling
144. Prediction of anti-cancer drug response by kernelized multi-task learning
     Mehmet Tan · 2016 · Artificial Intelligence in Medicine
145. Machine-Learning Implementation in Clinical Anesthesia: Opportunities and Challenges
     Danton S. Char, Alyssa M. Burgart · 2020 · Anesthesia & Analgesia
146. Machine learning approach to predict postoperative opioid requirements in ambulatory surgery patients
     Akira A. Nair, Mihir Velagapudi, Jonathan A. Lang, Lakshmana D. Behara, Ravitheja Venigandla, Nishant Velagapudi, Christine T. Fong, Mayumi Horibe, John D. Lang, Bala G. Nair · 2020 · PLoS ONE
147. Understanding the neurovascular unit at multiple scales: Advantages and limitations of multi-photon and functional ultrasound imaging
     Alan Urban, Lior Golgher, Clément Brunner, Amos Gdalyahu, Hagai Har-Gil, David Kain, Gabriel Montaldo, Laura Sironi, Pablo Blinder · 2017 · Advanced Drug Delivery Reviews
148. A novel framework for the identification of drug target proteins: Combining stacked auto-encoders with a biased support vector machine
     Qi Wang, Yanghe Feng, Jincai Huang, Tengjiao Wang, Guangquan Cheng · 2017 · PLoS ONE
149. Drug-Target Interaction Prediction in Drug Repositioning Based on Deep Semi-Supervised Learning
     Meriem Bahi, Mohamed Batouche · 2018 · IFIP advances in information and communication technology
150. Using Machine Learning to Predict Synergistic Antimalarial Compound Combinations With Novel Structures
     Daniel J. Mason, Richard T. Eastman, Richard P. I. Lewis, Ian P. Stott, Rajarshi Guha, Andreas Bender · 2018 · Frontiers in Pharmacology
151. Predicting Efflux Ratios and Blood-Brain Barrier Penetration from Chemical Structure: Combining Passive Permeability with Active Efflux by P-Glycoprotein
     Elena Dolghih, Matthew P. Jacobson · 2012 · ACS Chemical Neuroscience
152. Artificial neural network‐based drug design for diabetes mellitus using flavonoids
     Jagdish C. Patra, Boon Heng Chua · 2010 · Journal of Computational Chemistry
153. Remote Monitoring of Treatment Response in Parkinson's Disease: The Habit of Typing on a Computer
     Michele Matarazzo, Teresa Arroyo‐Gallego, Paloma Montero, Verónica Puertas‐Martín, Ian Butterworth, Carlos S. Mendoza, María J. Ledesma‐Carbayo, María José Catalán, José Antonio Molina, Félix Bermejo‐Pareja et al. · 2019 · Movement Disorders
154. Improved fragment sampling for ab initio protein structure prediction using deep neural networks
     Tong Wang, Yanhua Qiao, Wenze Ding, Wenzhi Mao, Yaoqi Zhou, Haipeng Gong · 2019 · Nature Machine Intelligence
155. Druggability Assessment in TRAPP Using Machine Learning Approaches
     Jui-Hung Yuan, Sungho Bosco Han, Stefan Richter, Rebecca C. Wade, Daria B. Kokh · 2020 · Journal of Chemical Information and Modeling
156. Deorphaning the Macromolecular Targets of the Natural Anticancer Compound Doliculide
     Gisbert Schneider, Daniel Reker, Tao Chen, Kurt Hauenstein, Petra Schneider, Karl‐Heinz Altmann · 2016 · Angewandte Chemie International Edition
157. Computational Drug Repositioning by Ranking and Integrating Multiple Data Sources
     Ping Zhang, Pankaj Agarwal, Zoran Obradovic A · 2013 · Lecture notes in computer science
158. Developing an in silico pipeline for faster drug candidate discovery: Virtual high throughput screening with the Signature molecular descriptor using support vector machine models
     Jonathan Jun Feng Chen, Donald P. Visco · 2016 · Chemical Engineering Science
159. Using machine learning to explain the heterogeneity of schizophrenia. Realizing the promise and avoiding the hype
     Neeraj Tandon, Rajiv Tandon · 2019 · Schizophrenia Research
160. Drug-Target Interactions: Prediction Methods and Applications
     Shanmugam Anusuya, Manish Kesherwani, Vishnupriya Kanakaveti, Vimala Antonydhason, Gnanendra Shanmugam, Devadasan Velmurugan, M. Michael Gromiha · 2016 · Current Protein and Peptide Science
161. Erratum to: Fragment-based in silico modeling of multi-target inhibitors against breast cancer-related proteins
     Alejandro Speck‐Planche, M. Natália D. S. Cordeiro · 2017 · Molecular Diversity
162. Design of Natural‐Product‐Inspired Multitarget Ligands by Machine Learning
     Francesca Grisoni, Daniel Merk, Lukas Friedrich, Gisbert Schneider · 2019 · ChemMedChem
163. Network topology and machine learning analyses reveal microstructural white matter changes underlying Chinese medicine Dengzhan Shengmai treatment on patients with vascular cognitive impairment
     Hui Lu, Junying Zhang, Ying Liang, Yanan Qiao, Caishui Yang, Xuwen He, Wenxiao Wang, Shaokun Zhao, Dongfeng Wei, He Li et al. · 2020 · Pharmacological Research
164. Role of breast cancer resistance protein (BCRP) as active efflux transporter on blood-brain barrier (BBB) permeability
     Prabha Garg, Rahul Dhakne, Vilas Belekar · 2014 · Molecular Diversity
165. Absorption, Distribution, Metabolism, Excretion, and Toxicity Evaluation in Drug Discovery. 14. Prediction of Human Pregnane X Receptor Activators by Using Naive Bayesian Classification Technique
     Huali Shi, Sheng Tian, Youyong Li, Dan Li, Huidong Yu, Xuechu Zhen, Tingjun Hou · 2014 · Chemical Research in Toxicology
166. SVM approach for predicting LogP
     Quan Liao, Jianhua Yao, Shengang Yuan · 2006 · Molecular Diversity
167. Generative Models for Artificially‐intelligent Molecular Design
     Gisbert Schneider · 2018 · Molecular Informatics
168. Prediction of Membrane Permeation of Drug Molecules by Combining an Implicit Membrane Model with Machine Learning
     S. Brocke, A. Degen, Alexander D. MacKerell, Bercem Dutagaci, M. Feig · 2018 · Journal of Chemical Information and Modeling
169. Predicting associations among drugs, targets and diseases by tensor decomposition for drug repositioning
     Wang, Ran, Li, Shuai, Cheng, Lixin, Wong, Man Hon, Leung, Kwong Sak · 2019 · BMC Bioinformatics
170. Future De Novo Drug Design
     Gisbert Schneider · 2014 · Molecular Informatics
171. Computational Prediction of Drug-Target Interactions via Ensemble Learning
     Ali Ezzat, Min Wu, Xiaoli Li, Chee-Keong Kwoh · 2018 · Methods in molecular biology
172. Identification of the gene signature reflecting schizophrenia’s etiology by constructing artificial intelligence‐based method of enhanced reproducibility
     Qingxia Yang, Yunxia Wang, Fengcheng Li, Zhang Song, Yongchao Luo, Yi Li, Jing Tang, Bo Li, Yu Chen, Weiwei Xue et al. · 2019 · CNS Neuroscience & Therapeutics
173. Improvement of Virtual Screening Results by Docking Data Feature Analysis
     Marcelino Arciniega, Oliver F. Lange · 2014 · Journal of Chemical Information and Modeling
174. A neural networks-based drug discovery approach and its application for designing aldose reductase inhibitors
     Lihong Hu, Guanhua Chen, Raymond Ming-Wah Chau · 2005 · Journal of Molecular Graphics and Modelling
175. Paul Ehrlich (1854-1915): man with the magic bullet.
     Tan SY, S Grimes · 2010 · PubMed
176. Drug response prediction by ensemble learning and drug-induced gene expression signatures
     Mehmet Tan, Ozan Fırat Özgül, Batuhan Bardak, Işıksu Ekşioğlu, Suna Sabuncuoğlu · 2018 · Genomics
177. Predicting drug-induced transcriptome responses of a wide range of human cell lines by a novel tensor-train decomposition algorithm
     M Iwata, Longhao Yuan, Qibin Zhao, Yasuo Tabei, Francois Berenger, Ryusuke Sawada, Sayaka Akiyoshi, Momoko Hamano, Yoshihiro Yamanishi · 2019 · Bioinformatics
178. ARPNet: Antidepressant Response Prediction Network for Major Depressive Disorder
     Chang, Buru, Choi, Yonghwa, Jeon, Minji, Lee, Junhyun, Han, Kyu-Man, Kim, Aram, Ham, Byung-Joo, Kang, Jaewoo · 2019 · Genes
179. PTML Modeling for Alzheimer’s Disease: Design and Prediction of Virtual Multi-Target Inhibitors of GSK3B, HDAC1, and HDAC6
     Valeria V. Kleandrova, Alejandro Speck‐Planche · 2020 · Current Topics in Medicinal Chemistry
180. CNS Permeability of Drugs Predicted by a Decision Tree
     Claudia Andrés, Michael Christopher Hutter · 2006 · QSAR & Combinatorial Science
181. Integrating network, sequence and functional features using machine learning approaches towards identification of novel Alzheimer genes
     Salma Jamal, Sukriti Goyal, Asheesh Shanker, Abhinav Grover · 2016 · BMC Genomics
182. Development of Predictive Models for Identifying Potential S100A9 Inhibitors Based on Machine Learning Methods
     Jihyeun Lee, Surendra Kumar, Sangyoon Lee, Sung Jean Park, Mi‐Hyun Kim · 2019 · Frontiers in Chemistry
183. Machine learning improved classification of psychoses using clinical and biological stratification: Update from the bipolar-schizophrenia network for intermediate phenotypes (B-SNIP)
     Suraj Sarvode Mothi, Mukund Sudarshan, Neeraj Tandon, Carol A. Tamminga, Godfrey D. Pearlson, John A. Sweeney, Brett A. Clementz, Matcheri S. Keshavan · 2018 · Schizophrenia Research
184. Repurposing drugs to treat l-DOPA-induced dyskinesia in Parkinson's disease
     Tom H. Johnston, Alix M.B. Lacoste, Naomi P. Visanji, Anthony Edward Lang, Susan Helen Fox, Jonathan M. Brotchie · 2018 · Neuropharmacology
185. Predicting adverse drug reactions of combined medication from heterogeneous pharmacologic databases
     Zheng, Yi, Peng, Hui, Zhang, Xiaocai, Zhao, Zhixun, Yin, Jie, Li, Jinyan · 2018 · BMC Bioinformatics
186. Cerebrospinal fluid proteomic patterns discriminate Parkinson's disease and multiple system atrophy
     Noriko Ishigami, Takahiko Tokuda, Masaya Ikegawa, Mika Komori, Takashi Kasai, Takayuki Kondo, Yumiko Matsuyama, Takashi Nirasawa, Herbert Thiele, Kei Tashiro et al. · 2012 · Movement Disorders
187. Three-class classification models of logS and logP derived by using GA–CG–SVM approach
     Hui Zhang, Mingli Xiang, Chang-Ying Ma, Qi Huang, Wei Li, Yang Ming Xie, Yu-Quan Wei, Shengyong Yang · 2009 · Molecular Diversity
188. ProSPr: Democratized Implementation of Alphafold Protein Distance Prediction Network
     W.M. Billings, Bryce Hedelius, Todd Millecam, David Wingate, Dennis Della Corte · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
189. A machine-learning approach to predicting hypotensive events in ICU settings
     Mina Chookhachizadeh Moghadam, Ehsan Masoumi Khalil Abad, Nader Bagherzadeh, Davinder S. Ramsingh, G.P. Li, Zeev N. Kain · 2020 · Computers in Biology and Medicine
190. A predictive-modeling based screening tool for prolonged opioid use after surgical management of low back and lower extremity pain
     Yi Zhang, Parastou Fatemi, Zachary A. Medress, Tej Deepak Azad, Anand Veeravagu, Atman Mukesh Desai, John Kevin Ratliff · 2020 · The Spine Journal
191. Drug development status for Alzheimer’s disease: present scenario
     Shubham Misra, Bikash Medhi · 2013 · Neurological Sciences
192. Machine Learning Classification Models to Improve the Docking‐based Screening: A Case of PI3K‐Tankyrase Inhibitors
     Vladimir P. Berishvili, Andrew E. Voronkov, Eugene V. Radchenko, Vladimir A. Palyulin · 2018 · Molecular Informatics
193. Construction of Quantitative Structure Activity Relationship (QSAR) Models to Predict Potency of Structurally Diversed Janus Kinase 2 Inhibitors
     Saw Simeon, Nathjanan Jongkon · 2019 · Molecules
194. Large-scale prediction of human kinase–inhibitor interactions using protein sequences and molecular topological structures
     Dongsheng Cao, Guanghua Zhou, Shao Liu, Liu‐Xia Zhang, Qing‐Song Xu, Min He, Yi‐Zeng Liang · 2013 · Analytica Chimica Acta
195. miRNA Targeting Drugs: The Next Blockbusters?
     Marco F. Schmidt · 2016 · Methods in molecular biology
196. Multi-channel PINN: investigating scalable and transferable neural networks for drug discovery
     Munhwan Lee, Hye‐Yeon Kim, Hyunwhan Joe, Hong‐Gee Kim · 2019 · Journal of Cheminformatics
197. Diverse classification models for anti-hepatitis C virus activity of thiourea derivatives
     Naveen Khatri, Viney Lather, А. К. Мадан · 2014 · Chemometrics and Intelligent Laboratory Systems
198. Screening for Dihydrofolate Reductase Inhibitors Using MOLPRINT 2D, a Fast Fragment-Based Method Employing the Naïve Bayesian Classifier: Limitations of the Descriptor and the Importance of Balanced Chemistry in Training and Test Sets
     Andreas Bender, Hamse Y. Mussa, Robert Charles Glen · 2005 · SLAS DISCOVERY
199. Predicting Rat and Human Pregnane X Receptor Activators Using Bayesian Classification Models
     Mohamed Diwan M. AbdulHameed, Danielle L. Ippolito, Anders Wallqvist · 2016 · Chemical Research in Toxicology
200. Development of MLR and SVM Aided QSAR Models to Identify Common SAR of GABA Uptake Herbal Inhibitors used in the Treatment of Schizophrenia
     Muhammed Marunnan Sahila, Pallikkara Pulikkal Babitha, Anitha Jabamalairaj, Srinivas Bandaru, Mukesh Yadav, Anuraj Nayarisseri, Victor Arokia Doss · 2016 · Current Neuropharmacology